Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

OBJECTIVE: This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis. DESIGN: A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induction phase in which patients with histologically c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut
Autors principals: Münch, Andreas, Bohr, Johan, Miehlke, Stephan, Benoni, Cecilia, Olesen, Martin, Öst, Åke, Strandberg, Lars, Hellström, Per M, Hertervig, Erik, Armerding, Peter, Stehlik, Jiri, Lindberg, Greger, Björk, Jan, Lapidus, Annika, Löfberg, Robert, Bonderup, Ole, Avnström, Sören, Rössle, Martin, Dilger, Karin, Mueller, Ralph, Greinwald, Roland, Tysk, Curt, Ström, Magnus
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2016
Matèries:
Inflammatory Bowel Disease
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717436/
https://ncbi.nlm.nih.gov/pubmed/25425655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2014-308363
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars